The process of brain development encompasses the intricate journey from conception to adulthood, characterized by the growth, connectivity, and maturation of the brain. It involves a sophisticated interplay of genetic, environmental, and experiential factors. During prenatal development, the brain initiates as a rudimentary structure, rapidly expanding and diversifying as neurons proliferate and migrate to their designated regions, establishing the foundational structure of the brain. Postnatally, the brain continues to evolve through various stages. Early childhood is distinguished by substantial synaptic pruning, wherein redundant connections are pruned while crucial ones are reinforced through experience-dependent plasticity, pivotal for acquiring fundamental skills and abilities. Throughout childhood and adolescence, the brain undergoes continual refinement and specialization, particularly in regions governing higher-order cognitive functions like the prefrontal cortex, which continues to develop into early adulthood, influencing decision-making, impulse control, and social behavior. Environmental influences, such as nutrition, stress, and sensory stimulation, profoundly shape brain development. Positive experiences, enriched environments, and nurturing relationships play a crucial role in fostering healthy brain development, whereas adverse experiences or neglect can impede progress and lead to developmental disruptions. Grasping the complexities of brain development is paramount for optimizing early childhood interventions, educational frameworks, and support systems to ensure individuals realize their full cognitive, emotional, and social potential.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States